We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of controlled substances in amounts exceeding legitimate
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA's comments on the Centers for Medicare & Medicaid Services’ and its contractors’ draft specifications for the two transfer of health information measures under development.
AHA responds to the US Department of Treasury Office of Tax Policy request for guidance on questions raised by new tax law.
AHA letter to FCC regarding concern about the unexpected and significant funding cuts for the Rural Health Care (RHC) program participants, announced in March by the Universal Service Administrative Company (USAC), the program administrator.
AHA comments to CMS on the proposed rule amending the definition of short-term, limited-duration health insurance.
AHA comments to the House Subcommittee on Health Energy and Commerce on bills related to the opioid crisis.
As the nation continues to struggle with the devastating public health crisis created by the opioid epidemic, it is encouraging to see the Committee on Health, Education, Labor & Pensions take
AHA reiterates support for legislation to align 42 CFR Part 2 with HIPAA.